Structure of molecule OATD-01

oral, first-in-class CHIT1/AMCase chitinase inh.

for sarcoidosis/lung fibrosis, Ph. Ib complete

from opt. of literature molecule

J. Med. Chem., Oct. 20, 2020

OncoArendi Therapeutics SA, Warsaw, PL

OATD-01 (OncoArendi Therapeutics oral, first-in-class CHIT1/AMCase chitinase inhibitor clinical candidate)


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.